On August 27, 2025, Moleculin Biotech, Inc. entered into a deal allowing existing warrant holders to exercise up to 16,216,216 shares, potentially raising about $6 million. New warrants covering 64,864,864 shares at $0.55 each will be issued, pending shareholder approval.